AI assistant
HEALTHEQUITY, INC. — Director's Dealing 2021
Jan 27, 2021
30722_dirs_2021-01-27_b34500af-a68d-4883-83e5-5a51e430a29c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HEALTHEQUITY, INC. (HQY)
CIK: 0001428336
Period of Report: 2021-01-25
Reporting Person: Kessler Jon (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-25 | Common Stock | S | 54858 | $84.4595 | Disposed | 350857 | Direct |
| 2021-01-25 | Common Stock | S | 56141 | $85.0581 | Disposed | 294716 | Direct |
| 2021-01-25 | Common Stock | S | 21448 | $86.1154 | Disposed | 273268 | Direct |
| 2021-01-25 | Common Stock | S | 17553 | $87.1275 | Disposed | 255715 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $41.28 | 2027-03-27 | Common Stock (17410) | 34820 | Indirect |
| Stock Option (right to buy) | $61.72 | 2028-03-27 | Common Stock (11965) | 23930 | Indirect |
| Stock Option (right to buy) | $73.61 | 2029-03-26 | Common Stock (12782) | 12782 | Indirect |
| Stock Option (right to buy) | $14.00 | 2024-07-30 | Common Stock (160000) | 160000 | Indirect |
| Stock Option (right to buy) | $41.28 | 2027-03-27 | Common Stock (34819) | 17409 | Direct |
| Stock Option (right to buy) | $61.72 | 2028-03-27 | Common Stock (35894) | 23929 | Direct |
| Stock Option (right to buy) | $73.61 | 2029-03-26 | Common Stock (51125) | 38343 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2020.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.75 to $84.74, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3), (4), and (5) of this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.75 to $85.74, inclusive.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.75 to $86.74, inclusive.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.76 to $87.58, inclusive.
F6: The option is immediately exercisable.
F7: The option will become exercisable as to 17,409 shares on March 27, 2021.
F8: The option will become exercisable as to 11,965 shares on March 27, 2021 and 11,964 shares on March 27, 2022.
F9: The option will become exercisable in annual installments of 12,781 shares on each of March 26, 2021, 2022 and 2023.